Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Statin use before diabetes diagnosis and risk of microvascular

Proposal for Standardization of Primary and Secondary Outcomes in

Recent advances in graves ophthalmopathy medical therapy: a

Biomedicines, Free Full-Text

Proposal for Standardization of Primary and Secondary Outcomes in

Current and Emerging Treatment Strategies for Graves' Orbitopathy

Management of Thyroid Eye Disease: A Consensus Statement by the

Traditional Chinese medicine in thyroid-associated orbitopathy

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label

Recent advances in graves ophthalmopathy medical therapy: a

Teprotumumab: Interpreting the Clinical Trials in the Context of

American Thyroid Association - Our look at the STAGO trial: What's

Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and